Helios

Epicutaneous immunotherapy may transform allergy treatment
Epicutaneous immunotherapy may transform allergy treatmentAs an allergy sufferer myself, I tend to pore over the journals and literature to learn what new exciting technologies may be on the horizon. When I came across epicutaneous immunotherapy (EPIT), my mind went in a multitude of different directions about the endless possibilities for both systemic and ocular allergy management.
Drug therapies, delivery systems advance for glaucoma carePharmacologic products and devices in development continue to gain momentum in the glaucoma treatment armamentarium.
Ocular insert overcoming glaucoma treatment challengesA bimatoprost-releasing ocular insert that rests in the conjunctival fornix (ForSight VISION5) lowered IOP in patients with ocular hypertension or glaucoma by an average of 4 to 6 mm Hg from baseline over 6 months.